Senior Principle Scientist - DMPK at enveda, Hyderabad
Open. Posted .
Discovery DMPK work at a clinical-stage biotech spans ADME assays, in vivo PK studies, LC-MS/MS method development and guidance for junior scientists. The role is in Hyderabad.
Applying opens the employer's page. Want jobs like this sent to you each morning? Open Elip.
| Location | Hyderabad, Telangana |
|---|---|
| Work mode | On-site |
| Experience | 8–9 years |
| Pay | Not stated by the employer |
| Role | Lab & Pharma Scientist |
| Skills asked for | DMPK, ADME, bioanalysis, in vitro ADME assays, in vivo PK studies, LC-MS/MS, Phoenix WinNonlin, NCA |
| Posted | 19 Nov 2026 |
Elip's summary
DMPK scientist at a clinical-stage, AI-enabled biotech discovering medicines. Applies ADME expertise to run in vitro ADME assays and in vivo PK studies, develop LC-MS/MS methods, and analyze PK data using Phoenix WinNonlin. Guides junior scientists in laboratory practice and supports drug discovery teams.
The job, in the employer's words
WHAT WE'RE LOOKING FOR
PhD in Pharmaceutical Sciences with 8+ years of post-PhD experience in a biotech or CRO discovery DMPK setting
Deep hands-on expertise in ADME and bioanalysis, with a proven track record of running in vitro ADME assays, in vivo PK studies and LC-MS/MS method development
Strong PK data analysis (NCA) skills using Phoenix WinNonlin or equivalent software
Experience guiding and mentoring junior scientists in a laboratory setting, with a strong commitment to lab safety and audit readiness
Clear communicator who can turn complex ADME and PK data into practical guidance for chemists and project teams
We hire for trajectory, not just credentials. If you meet most of the above and care deeply about this problem, we want to hear from you.
ABOUT ENVEDA
We're a clinical-stage, AI-enabled biotech discovering medicines four times faster than the industry standard.We recently raised $150M in a Series D, reached unicorn status, and advanced our first drug into Phase 2 trials. Forbes named us one of America's Best Startup Employers. Newsweek recognized us as a Top 100 Most Loved Workplace. We're building something rare — and we're just getting started!
Additional Information
If you’re passionate about innovation and impact, we encourage you to apply—even if you don’t meet every requirement.
Our Values: Curiosity | Agency | Journey | Charity | Unity
Benefits: Culture | Medical | Block Leaves | Work-Life Harmony
At Enveda, we’re building a place where everyone can do the best work of their life. We are an equal opportunity employer and value diversity in all its forms.
👉Apply now and join a team committed to shaping the future of drug discovery.
Enveda is protecting Job Seekers
We care deeply about creating a safe, respectful experience for every applicant, so we wanted to share a few guidelines to help you spot anything that doesn’t feel right. You’ll always meet real Enveda team members through video or in-person conversations before receiving an offer.
All communication from us will come from an @enveda.com or @envedabio.com email address. We’ll never ask you to purchase equipment, send money, or share sensitive banking details as part of any step in our recruiting process.
If something feels off or you’re unsure whether a message is truly from Enveda, please reach out at anytime at recruiting@enveda.com.
About enveda
Headquartered in Boulder, founded in 2019.
- People in Elip's index who work here
- 380
- Typical time at enveda
- 17 months
- Typical career length so far
- 10.3 years
Largest teams
- Research136 people
- Engineering28 people
- Leadership15 people
- Operations15 people
Where people here worked before
- Syngene International Limited11 people
Totals from public professional profiles in Elip's index; any group under ten people is left out.
Similar open jobs
About this page
Elip lists jobs that employers publish on their own careers sites, never copies from job boards. This one comes from enveda's listing on Lever, posted 19 Nov 2026. The summary is Elip's; the description is the employer's. When the job closes, this page says so.